Handhelds in Healthcare Discussed in Newast Kalorama Information Market Research Report10 Feb 2012 • by Natalie Aster
Handheld prothrombin time (PT) monitors are similar to monitors which test the level of insulin for diabetes patients. Prothrombin time is the testing of anticoagulant drugs in a patient’s blood such as warfarin sodium (Coumadin) in patients with conditions such as hyperhomocystinemia, elevated factor VIII levels, dysfibrinogenemia, factor XII deficiency and disorders of plasmin generation, and to assess acquired conditions, such as pregnancy, postoperative state, antiphospholipid syndrome, hyperhomocystinemia, among others.
In the new market report “Handhelds in Healthcare: The World Market for PDAs, Tablet PCs, Handheld Monitors & Scanners” by Kalorama Information prothrombin levels are also monitored along with other tests (such as aspirate aminotransferase and alanine aminotransferase) to help evaluate liver function.
Handhelds in Healthcare: The World Market for PDAs, Tablet PCs, Handheld Monitors & Scanners
Published: February, 2012
Price: US$ 3.500,00
The handheld option has become very useful in testing in the field, at the bedside or for home patient self-testing. This device allows for quick results and reduces the need for laboratory prothrombin time testing. The report focuses on two primary segments:
Patient Monitoring Devices, including:
- Blood pressure devices
- Pulse oximeters
- ECG/EKG monitors
- Diabetes insulin monitors
- Prothrombin time monitors
- Fetal heart monitors
Administrative Devices, including:
- Smartphones and PDAs
- Tablet PCs
- Inventory/Medication Management Scanners
More information can be found in the report “Handhelds in Healthcare: The World Market for PDAs, Tablet PCs, Handheld Monitors & Scanners” by Kalorama Information.
To order the report or ask for sample pages contact email@example.com